latest news releases from the newsroom
Baron & Budd
Investor Alert: Update On Options Backdating Actions Involving Analog Devices, Inc. -- ADI
DALLAS, Aug. 25, 2006 (PRIMEZONE) -- The law firm of Baron & Budd, P.C. is investigating the option-granting practices of Analog Devices, Inc. Baron & Budd has uncovered an apparent scheme by Analog Devices to grant stock options to its executives at unusually favorable dates and prices to the detriment of Analog Devices and its shareholders. During at least a four-year period, Analog Devices issued its executives option grants for millions of shares of stock by retroactively selecting a date when the stock traded at a lower price thereby creating an illicit gain.
Saxo Bank A/S
Saxo Bank Delivers Solid Half-Year Earnings
GENTOFTE, Denmark, Aug. 25, 2006 (PRIMEZONE) -- Saxo Bank continued to post solid growth in earnings and overall business during first half-year 2006. The bank reported profits before tax of DKK 123m compared with DKK 73m during the corresponding period in 2005. Total client deposits also increased by 37% compared to the value of client deposits placed with the bank at the end of the same period in the previous year.
Gardant Pharmaceuticals, Inc.
Gardant Pharmaceuticals Signs Agreement to be Acquired by Switch Pharma
NEW YORK, Aug. 25, 2006 (PRIMEZONE) -- Gardant Pharmaceuticals, Inc. (Pink Sheets:GRDP) Gardant Pharmaceuticals today announced it has signed an agreement to be acquired by Switch Pharma Ltd. Shares of Switch Pharma Ltd., which is currently in the process of going public in London, will be issued to acquire Gardant Pharmaceuticals. Pursuant to the agreement, the Switch Pharma Ltd. shares issued in the transaction must be trading for at least $1.38 per share when the shares of Switch Pharma Ltd. commence trading publicly in London. Shareholders of Gardant will receive one share of Switch Pharma for every Gardant share owned. The transaction is expected to close on September 30th subject to requisite approvals.
Baron & Budd
Investor Alert: Update on Options Backdating Actions Involving Brooks Automation, Inc. -- BRKS
DALLAS, Aug. 25, 2006 (PRIMEZONE) -- The law firm of Baron & Budd, P.C. is investigating the option-granting practices of Brooks Automation, Inc. Baron & Budd has uncovered an apparent scheme to grant stock options to executives at unusually favorable dates and prices to the detriment of Brooks Automation and its shareholders. Executives at Brooks Automation received hundreds of thousands of option grants over a six-year period whereby they extracted millions in illicit profits. The Wall Street Journal reported the likelihood of Brooks' option grants being legitimate as 1 in 9 million.
Port of Houston Authority
PHA Commission Considers $9.9 Million Share of Channel Dredging Project
HOUSTON, Aug. 25, 2006 (PRIMEZONE) -- The Port Commission of The Port of Houston Authority will consider funding a $9.9 million share of a Houston Ship Channel dredging and maintenance project and several other matters at its public meeting on Monday, August 28, beginning at 1 p.m. in the board room of the PHA Executive Building, 111 East Loop North (Exit 29 off Loop 610) in Houston. Chairman Jim Edmonds will preside over the meeting with Commissioner Steve Phelps, Commissioner Jim Fonteno, Commissioner Kase Lawal, Commissioner Jimmy Burke, Commissioner Janiece Longoria and Commissioner Elyse Lanier.
TASER International, Inc.
TASER International Receives Follow-On Orders for TASER X26 Devices from Three Florida Law Enforcement Agencies
SCOTTSDALE, Ariz., Aug. 25, 2006 (PRIMEZONE) -- TASER International, Inc. (Nasdaq:TASR) a market leader in advanced electronic control devices today announced that it has received three follow-on orders for TASER(r) X26 units and accessories from law enforcement agencies in the state of Florida. The Broward County Sheriff's Office, the Hillsborough County Sheriff's Office, and the Miami-Dade Police Department all placed orders for the TASER X26 devices and accessories to supplement the TASER units that are already in deployment at each agency.
Avitech Lifesciences Inc.
Avitech Lifesciences Avitol (Alternative Against Avian Flu) Now Available
CARSON CITY, Nev., Aug. 25, 2006 (PRIMEZONE) -- Avitech Lifesciences Inc. (Other OTC:AVLF) announced today that Avitol, the homeopathic product formulated to aid against the Avian Flu, is now available for distribution. Avitol is based on various acid derivatives as well as other active ingredients including high potency anti-oxidants. It has been developed with an advanced delivery system and is intended to offer a homeopathic alternative to most virulent strains of Avian Flu.